Shiga toxin subtypes display dramatic differences in potency - Wikidata - wikimedia - TriplyDB

Shiga toxin subtypes display dramatic differences in potency

Shiga toxin subtypes display dramatic differences in potency

http://www.wikidata.org/entity/Q34739913

about

Hemolytic uremic syndrome: new developments in pathogenesis and treatment Do the A subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2?Shiga Toxin (Stx) Classification, Structure, and Function Purification and characterization of Shiga toxin 2f, an immunologically unrelated subtype of Shiga toxin 2 Serine protease EspP from enterohemorrhagic Escherichia coli is sufficient to induce shiga toxin macropinocytosis in intestinal epithelium.Shiga toxin pathogenesis: kidney complications and renal failure.Mouse in vivo neutralization of Escherichia coli Shiga toxin 2 with monoclonal antibodies Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway.The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012.New high-affinity monoclonal antibodies against Shiga toxin 1 facilitate the detection of hybrid Stx1/Stx2 in vivo.Isolation and identification of an Enterobacter cloacae strain producing a novel subtype of Shiga toxin type 1.Shiga toxin binding to glycolipids and glycans.The highly virulent 2006 Norwegian EHEC O103:H25 outbreak strain is related to the 2011 German O104:H4 outbreak strain.Haemolytic-uraemic syndrome with bacteraemia caused by a new hybrid Escherichia coli pathotype.Recent advances in understanding enteric pathogenic Escherichia coli.Carriage of stx2a differentiates clinical and bovine-biased strains of Escherichia coli O157.Failure of manganese to protect from Shiga toxin.Identification of a wide range of motifs inhibitory to shiga toxin by affinity-driven screening of customized divalent peptides synthesized on a membrane Predicting the public health benefit of vaccinating cattle against Escherichia coli O157 Development of monoclonal antibodies and immunoassays for sensitive and specific detection of Shiga toxin Stx2f.A prospective case-control and molecular epidemiological study of human cases of Shiga toxin-producing Escherichia coli in New Zealand.A polyclonal antibody based immunoassay detects seven subtypes of Shiga toxin 2 produced by Escherichia coli in human and environmental samples.Characterization of Shiga toxin-producing Escherichia coli isolated from healthy pigs in China Top-down proteomic identification of Shiga toxin 2 subtypes from Shiga toxin-producing Escherichia coli by matrix-assisted laser desorption ionization-tandem time of flight mass spectrometry.Glycolipid binding preferences of Shiga toxin variants.Shiga toxin 2 subtypes of enterohemorrhagic E. coli O157:H- E32511 analyzed by RT-qPCR and top-down proteomics using MALDI-TOF-TOF-MS.Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin.Genetic features differentiating bovine, food, and human isolates of shiga toxin-producing Escherichia coli O157 in The Netherlands.Affinity-Based Screening of Tetravalent Peptides Identifies Subtype-Selective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition.A single-step purification and molecular characterization of functional Shiga toxin 2 variants from pathogenic Escherichia coli Whole Genome Sequencing demonstrates that Geographic Variation of Escherichia coli O157 Genotypes Dominates Host Association Identification and Characterization of Novel Compounds Blocking Shiga Toxin Expression in Escherichia coli O157:H7.Comparative genomics and stx phage characterization of LEE-negative Shiga toxin-producing Escherichia coli Mass Spectrometry-Based Method of Detecting and Distinguishing Type 1 and Type 2 Shiga-Like Toxins in Human Serum Public health value of next-generation DNA sequencing of enterohemorrhagic Escherichia coli isolates from an outbreak.Lambda Red-mediated Recombineering in the Attaching and Effacing Pathogen Escherichia albertii Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli New Monoclonal Antibodies against a Novel Subtype of Shiga Toxin 1 Produced by Enterobacter cloacae and Their Use in Analysis of Human Serum.Binding of Pk-trisaccharide analogs of globotriaosylceramide to Shiga toxin variants.

P2860

Q24613517-66ABFE24-8094-47EC-A012-4AAC154D18B1 Q26858938-6038B24F-DFB3-42F0-91A0-94D46F36042C Q27021676-A2E91A85-BC4E-40B1-8DF2-D37653D2C24A Q28488900-01F216C8-FE46-4CD0-B9DF-4FBD466D6ABF Q30418173-EA00ACD9-E9D2-484F-8842-3EBDAC9611CB Q33397541-462CFBBE-D1EC-4419-B85F-07137BE0BF0E Q33411089-E3ECAA7A-547F-43E3-B857-D61DC39D3BD5 Q33418482-F7520D0F-4379-4CFE-A74B-F437D5F542CB Q33426867-EF3D76C4-55B9-4B68-96B2-02403ED5F8B4 Q33429632-64F1C953-2740-4DD0-82F7-E02233637B00 Q33734620-BEEA96D0-B014-4386-82E4-F450A1474D97 Q33900032-01DF8D2F-4746-4BB6-AABC-1B8218D8C772 Q34163196-2D35751D-488D-4029-B331-039E481D4FF3 Q34189292-1AFE0206-11ED-444F-8494-09D92FB751DA Q34286494-52DAAEC6-B849-433C-BFBD-B23F23975E90 Q34375210-BEFD52E9-DA85-4803-BB66-0E447ED2712B Q34512492-C6C7B048-45EC-40B9-B878-BAB28DEB8833 Q34854599-AFB6BCD9-41E3-4281-AACF-E0FE5FFB8611 Q34933393-2D903B82-DED5-4C32-8DF8-253BBD983181 Q34991352-2AFB7738-DF0B-4F46-8569-BAB99237FAE7 Q34999780-5F4AF9F9-8024-4A88-8470-274996FE92AB Q35002251-8A6D625F-44F2-4AF3-B34E-A1B5EB3A1DAE Q35022739-10B3EF1A-B9B9-4322-9E81-9B878D8E562D Q35083745-0C30C088-9416-443A-9C21-1E1FBCBB5F6F Q35105318-45635D00-8875-4381-AA30-C2299A31151F Q35199053-E423D636-BA45-40F2-9BDA-C047B843FFB4 Q35558583-74F1D8A2-7668-4C18-A67A-B42C0862B47C Q35673972-B425351D-889A-4E40-A7EA-B36D62305BAC Q35807170-C8D0C176-E16D-44A3-9AEF-C901444C360B Q36068651-6E3A3313-C237-4073-A666-2A832EA090EB Q36126033-07342A3C-7508-4C31-8988-3C9C80EF2CDE Q36128873-1614224A-680F-4FE5-A866-BEECF3F54518 Q36222964-5B0B2C13-108F-4BCB-8884-BFEF136D965E Q36377423-5804D41F-3FD1-4A99-9776-8E06C241A5A1 Q36401470-06D54DF9-68CC-4BDF-89D1-9C9E18728D47 Q36506461-727A7DF5-E11A-4A7C-8531-D522D50DE025 Q36538725-76A01BD8-A735-497D-8529-8FF1DD95238F Q36818691-17176BEB-B67A-4AE8-B1D7-29C547ED3A4D Q36891324-B1320220-00D6-4117-9054-8EB1443E7CF6 Q37036097-E4F13C1F-7C86-4755-89DC-54E17C426A85

P2860

Shiga toxin subtypes display dramatic differences in potency

http://www.wikidata.org/entity/Q34739913

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Shiga toxin subtypes display dramatic differences in potency

@ast

Shiga toxin subtypes display dramatic differences in potency

@en

Shiga toxin subtypes display dramatic differences in potency

@nl

type

label

Shiga toxin subtypes display dramatic differences in potency

@ast

Shiga toxin subtypes display dramatic differences in potency

@en

Shiga toxin subtypes display dramatic differences in potency

@nl

prefLabel

Shiga toxin subtypes display dramatic differences in potency

@ast

Shiga toxin subtypes display dramatic differences in potency

@en

Shiga toxin subtypes display dramatic differences in potency

@nl

P1433

Q34739913-709B3591-1CE9-4046-AFC2-5045DEC9B9D8

P1476

Q34739913-7ACF22C1-F081-45EF-AE29-E3F5E758C3D8

P2093

Q34739913-69D7D88F-BE76-489E-96BD-C69CC3A73159

Q34739913-6F80E311-218C-4F2E-BE8F-97B360AE5AC9

Q34739913-82D8FB75-FD75-41E4-A03F-4532879A3AB0

Q34739913-96F74DA9-3663-4590-90D8-E1602D5DB762

P2860

Q34739913-14354E6F-95AA-44D0-8BA1-01364AB4AE83

Q34739913-1E3D97B6-7603-4FA9-89BA-BEC66A9B1757

Q34739913-20B3BC37-7224-4F2D-A5D8-EF578D6732BF

Q34739913-24D54568-A9A9-4B2C-BC72-09EC97C46379

Q34739913-24EB58B6-829D-470B-AED8-B0A587CA6E20

Q34739913-2F871A9B-113C-4466-AA16-097CBF197628

Q34739913-31450797-B2E5-41A2-9901-A6EE2332A1DD

Q34739913-34BF9DE7-3FC9-4389-9A73-52991AD28E84

Q34739913-3F279774-789D-46CF-94E6-E757EEAC10C5

Q34739913-4730B9B9-3F12-4A8F-A13C-2B52D3EF4735

P304

Q34739913-108AFFC3-4D7D-42F8-B992-FD3F3D5D7F83

P31

Q34739913-1AF3349B-60AE-4431-9586-459DEFC8FEB1

P356

Q34739913-9CF94220-6E07-49CB-AE29-44CFDBD47D5A

P407

Q34739913-6E810569-FD9F-4494-B33E-A6735643AA08

P433

Q34739913-9572E40A-14A2-4E23-A477-DC48F16B9980

P478

Q34739913-3521B026-FB80-433C-9AEF-3C2AE65D523B

P50

Q34739913-D1B153DA-645C-43B5-8685-61A3A436EC80

P577

Q34739913-834E37A9-ED0C-43BE-B082-83156345F93A

P698

Q34739913-351757CE-581A-407B-BC48-E39C1C92195B

P932

Q34739913-1FDE2AF1-5389-4D56-818F-5A4536E62184

P356

P1433

Infection and Immunity

P1476

Shiga toxin subtypes display dramatic differences in potency

@en

P2093

Christine A Pellino

http://www.w3.org/2001/XMLSchema#string

Cynthia A Fuller

http://www.w3.org/2001/XMLSchema#string

Jane E Strasser

http://www.w3.org/2001/XMLSchema#string

Michael J Flagler

http://www.w3.org/2001/XMLSchema#string

P2860

Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities

Shiga toxin 2 targets the murine renal collecting duct epithelium

A mutant Shiga-like toxin IIe bound to its receptor Gb(3): structure of a group II Shiga-like toxin with altered binding specificity

Molecular Basis of Differential B-Pentamer Stability of Shiga Toxins 1 and 2

Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3

Rapid apoptosis induced by Shiga toxin in HeLa cells.

Phylogenetic analysis of Shiga toxin 1 and Shiga toxin 2 genes associated with disease outbreaks.

Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model.

Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.

P304

1329-1337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.01182-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21199911

http://www.w3.org/2001/XMLSchema#string

P932

3067513

http://www.w3.org/2001/XMLSchema#string